Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Connect Biopharma Holdings Ltd CNTB

Healthcare Biotechnology
Connect Biopharma Holdings Limited is a global clinical-stage biopharmaceutical company focused on improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research. It is building a pipeline of proprietary small molecules and antibodies, using functional T cell assays, to screen and discover potent product candidates... see more

Recent & Breaking News (NDAQ:CNTB)

Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom California

GlobeNewswire February 6, 2023

Connect Biopharma Provides Business and Clinical Development Program Update

GlobeNewswire December 30, 2022

Connect Biopharma to Present at the San Francisco Biotech Showcase in January

GlobeNewswire December 19, 2022

Connect Biopharma Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement

GlobeNewswire December 2, 2022

Connect Biopharma To Present at Upcoming Investor and Scientific Conferences

GlobeNewswire October 27, 2022

CORRECTING and REPLACING -- Connect Biopharma Reports CBP-201 Achieved All Primary and Key Secondary Endpoints in Pivotal Atopic Dermatitis (AD) Trial in China

GlobeNewswire October 4, 2022

Connect Biopharma Reports CBP-201 Achieved All Primary and Key Secondary Endpoints in Pivotal Atopic Dermatitis (AD) Trial in China

GlobeNewswire October 4, 2022

Connect Biopharma to Host a Conference Call Tuesday, October 4 to Discuss Topline Results for the Pivotal Trial in China of Lead Candidate, CBP-201, in Patients with Moderate-to-Severe Atopic Dermatitis

GlobeNewswire October 3, 2022

Connect Biopharma Reports First Half 2022 Financial Results and Provides Business Update

GlobeNewswire September 13, 2022

Connect Biopharma to Report First Half 2022 Financial Results on September 13

GlobeNewswire September 1, 2022

Connect BioPharma Successfully Completes CBP-174 Phase 1 Single Ascending Dose Study

GlobeNewswire August 30, 2022

Connect Moves Forward CBP-201 Top-Line Results Timeline for Pivotal China Atopic Dermatitis Trial to Second Half 2022

GlobeNewswire July 11, 2022

Connect Biopharma Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement

GlobeNewswire June 17, 2022

Connect Biopharma to Participate at the Jefferies Healthcare Conference

GlobeNewswire June 2, 2022

Connect Biopharma Presents CBP-201 Target Engagement and Immune Modulation Data at the Society for Investigative Dermatology Annual Conference

GlobeNewswire May 17, 2022

Connect Biopharma Announces Week 12 Top-Line Results from Phase 2 CBP-307 Trial in Patients with Moderate-to-Severe Ulcerative Colitis

GlobeNewswire May 3, 2022

Connect Biopharma Reports Full Year 2021 Financial Results and Provides Business Update

GlobeNewswire March 31, 2022

Connect Biopharma Appoints Autoimmune and Immunology Expert Chin Lee, MD, MPH as Chief Medical Officer

GlobeNewswire March 1, 2022

Connect Biopharma to Participate at the SVB Leerink 11th Annual Global Healthcare Conference

GlobeNewswire February 9, 2022

Connect Biopharma Presents Data and Analyses from the Global Phase 2b Trial of CBP-201 at the Maui Derm Conference

GlobeNewswire January 24, 2022